Accepted at 10:23 p.m. Oct, 31, 2023 by dollajas
Author: Fikthenig
Related Note: 1578927678153
Rationale for change

This isn't right. The biggest risk factor is H. Pylori which is the main risk factor that leads to chronic gastritis from around the antrum area. Autoimmune is primarily a risk factor for chronic gastritis around the body and fundus. Additionally, PUBmed states that, "Gastric cancer can be divided into adenocarcinomas of the diffuse and the intestinal type according to the Lauren classification.1 Intestinal type gastric carcinomas are associated with Helicobacter pylori associated chronic gastritis, atrophy, and intestinal metaplasia, which are thought to be precursors of the dysplastic changes that evolve into this type of carcinoma", clearly stating that the h.pylori version is the culprit.

Text Text
Extra
- Also called chronic atrophic metaplastic gastritis

- The intestinal-type is the end-result of an inflammatory process that progresses from chronic gastritis to atrophic gastritis and finally to intestinal metaplasia and dysplasia
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
* old grandfather in gastritis video on third sketch
 

Watch Gastric Dysmotility & Cancer
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#AMBOSS::uWapMj #PANCE::EOR::Surgery #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::08_Gastric_cancer::*Adenocarcinoma::Intestinal !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-GI::GI-Pathology #AK_Step1_v12::#AMBOSS::uWapMj #AK_Step2_v12::#SketchyIM::10_Gastroenterology::02_Esophageal_&_Gastric_Disorders::05_Gastric_Cancer #AK_Step2_v12::#SketchyIM::10_Gastroenterology::Retired_Lesson::01_Esophageal_&_Gastric_Disorders::05_Gastropathy_Gastritis_Gastric_Ulcer_[OLD_VERSION] #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_GI::GI_Pathology #AK_Step1_v12::#B&B::09_GI::03_Clinical_Gastroenterology::08_Gastric_Disorders #AK_Step2_v12::#AMBOSS::21aTTj #AK_Step2_v12::#B&B::06_GI::01_Esophagus_and_Stomach::03_Gastric_Disorders::Extra #AK_Step1_v12::^Systems::GI::JBadds #AK_Step1_v12::#AMBOSS::21aTTj #AK_Step1_v12::#AMBOSS::jda_pj #AK_Step1_v12::#AMBOSS::braHfN #AK_Step1_v12::#OME::Clinical::Intern_Bootcamp #AK_Step1_v12::^Other::^HighYield::3-HighYield-temporary #AK_Step2_v12::#B&B::06_GI::01_Esophagus_and_Stomach::04_Gastric_Cancer #AK_Step1_v12::!FLAG_THESE_CARDS::SketchyPathAdds #PANCE::GI::neoplasms #AK_Step2_v12::#AMBOSS #AK_Step1_v12::^Other::^EXPN::JBadd #AK_Step2_v12::#SketchyIM::10_Gastroenterology::01_Approach_to_Abdominal_Pain::01_Upper_Abdominal_Pain_DDx #PANCE::EOR::IM #AK_Step1_v12::#SketchyPath::05_GI::01_Esophageal_&_Gastric_Disorders::04_Gastric_Dysmotility_&_Cancer #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Esophageal_and_Gastric_Pathology::07_Malignant_Gastric_Pathology